ENAH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.840200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.884750E-01
Normal-vs-Stage2
1.497950E-02
Normal-vs-Stage3
2.002200E-01
Normal-vs-Stage4
3.894200E-01
Stage1-vs-Stage2
2.037400E-01
Stage1-vs-Stage3
5.652800E-01
Stage1-vs-Stage4
4.339600E-02
Stage2-vs-Stage3
7.179000E-01
Stage2-vs-Stage4
2.908600E-01
Stage3-vs-Stage4
3.852800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.422600E-03
Normal-vs-AfricanAmerican
3.709800E-01
Normal-vs-Asian
7.551600E-02
Caucasian-vs-AfricanAmerican
1.572850E-01
Caucasian-vs-Asian
9.655000E-01
AfricanAmerican-vs-Asian
3.387000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.819830E-02
Normal-vs-Female
7.117000E-03
Male-vs-Female
9.271200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.111620E-01
Normal-vs-Age(41-60Yrs)
6.107800E-02
Normal-vs-Age(61-80Yrs)
6.322100E-03
Normal-vs-Age(81-100Yrs)
2.182600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.341410E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.774800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.237800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.236160E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.923800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.206800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.182800E-03
Normal-vs-Daily Drinker
1.840770E-01
Normal-vs-Weekly Drinker
9.148100E-02
Normal-vs-Occasional Drinker
1.252550E-01
Normal-vs-Social Drinker
2.511800E-01
Non Drinker-vs-Daily Drinker
1.405610E-01
Non Drinker-vs-Weekly Drinker
4.166400E-01
Non Drinker-vs-Occasional Drinker
2.453600E-01
Non Drinker-vs-Social Drinker
2.349800E-01
Daily Drinker-vs-Weekly Drinker
5.629600E-02
Daily Drinker-vs-Occasional Drinker
3.788000E-02
Daily Drinker-vs-Social Drinker
4.999900E-02
Weekly Drinker-vs-Occasional Drinker
8.031400E-01
Weekly Drinker-vs-Social Drinker
6.109800E-01
Occasional Drinker-vs-Social Drinker
7.579000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.690000E-01
Normal-vs-Grade 2
7.871600E-02
Normal-vs-Grade 3
9.424300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.564800E-01
Grade 1-vs-Grade 3
1.363220E-01
Grade 1-vs-Grade 4
2.690000E-01
Grade 2-vs-Grade 3
3.797000E-01
Grade 2-vs-Grade 4
7.871600E-02
Grade 3-vs-Grade 4
9.424300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.106000E-02
Normal-vs-NonDiabetic
5.718400E-03
Diabetic-vs-NonDiabetic
6.543200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.223590E-01
Normal-vs-NoPancreatitis
6.718000E-03
Pancreatitis-vs-NoPancreatitis
5.209400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.941900E-03
Normal-vs-N1
1.267750E-02
N0-vs-N1
1.411840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.520000E-02
Normal-vs-TP53-NonMutant
6.057100E-03
TP53-Mutant-vs-TP53-NonMutant
9.909600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
